Ledger.Open graph →

SEC Form D · Amendment · filed August 31, 2016

BeneVir Biopharm, Inc

Offering

$12.0M

Sold

$6.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Gaithersburg, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Matthew C. Mulvey · Gaithersburg, MDExec · Director Katherine A. Sacksteder · Gaithersburg, MDExec · Director Cherine C. Plumaker · Gaithersburg, MDDirector David C. Kirn · Emeryville, CADirector David C. Present · New York, NYDirector Cherine C. Plumaker · Gaithersburg, MDDirector Nicole Emanuel · SAN FRANCISCO, CAExec · Director Susan Lyne · SAN FRANCISCO, CAExec · Director David L. Montanaro · SAN FRANCISCO, CAExec · Director Mark Larsen · Kaysville, UTExec · Director Christina M. Berzins · Timonium, MDDirector David C. Kirn · Emeryville, CADirector David C. Present · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗